Tech Company Financing Transactions
Fluxion Biosciences Funding Round
Fluxion Biosciences secured a $6.9 million Series B financing round on 11/9/2007. Investors included Claremont Creek Ventures, Kodiak Venture Partners and Life Science Angels.
Transaction Overview
Company Name
Announced On
11/9/2007
Transaction Type
Venture Equity
Amount
$6,850,000
Round
Series B
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1600 Harbor Bay Pkwy. 150
Alameda, CA 94502
USA
Alameda, CA 94502
USA
Phone
Website
Email Address
Overview
Innovative microfluidics based tools for cellular analysis. Main Products: IsoFlux: Molecular analysis of circulating tumor cells (CTC). BioFlux: in vivo conditions for live cell analysis. IonFlux: Automated patch clamp system with continuous flow.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeff Jensen
Chief Technical Officer
Cristian Zanetti
Vice President
Ali Yehia
Browse more venture capital transactions:
Prev: 11/9/2007: TAKKLE venture capital transaction
Next: 11/9/2007: JoMaJa venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs